OCTAPLASLG groupe sanguin AB subst sèche c solv

7680697800027 CH-69780 B05AA 06.01.1.
OCTAPLASLG groupe sanguin AB subst sèche c solv
OCTAPLASLG groupe sanguin AB subst sèche c solv
OCTAPLASLG groupe sanguin AB subst sèche c solv
1 / 3
google

Details

Product number
6978001
CPT
-
Packaging group
-
Unit
Blutgruppe AB (1 Durchstechflasche mit Pulver und 1 Beutel mit Lösungsmittel, Transferset und Zubehör)
Composition
Praeparatio cryodesiccata: proteina plasmatis humani 9-14 g, natrii citras dihydricus, natrii dihydrogenophosphas dihydricus, acidum citricum monohydricum, acidum phosphoricum, glycinum, pro vitro corresp. natrium <40 mmol. Solvens: aqua ad iniectabile pro charta.

Articles (1)

octaplasLG, Pulver und Lösungsmittel zur Herstellung einer Infusionslösung
Pulver
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
02/05/2025
Professional SmPC
Français
02/05/2025
Professional SmPC
Italien
02/05/2025

Detailed composition

Substance Quantity Type Category
PRC
- Substance Wirkstoff (Principe actif)
SOLV
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HBESI

Authorization holder

Octapharma AG

8853 Lachen SZ

Authorization information

Swissmedic authorization number
69780
Drug name
octaplasLG, Pulver und Lösungsmittel zur Herstellung einer Infusionslösung
Galenic form
PULMI
ATC Code
B05AA
Authorization status
Z
Dispensation category
B
First authorization
12/11/2024
Authorization expiration date
11/11/2029
IT number
06.01.1.
Domain
Human medicine
Field of application
komplexe Störungen des Hämostase-Systems ohne Möglichkeit einer differenzierten Therapie, wie z.B. Verbrauchskoagulopatie (DIC)

Packaging details

Description (FR)
OCTAPLASLG groupe sanguin AB subst sèche c solv
Description (DE)
OCTAPLASLG Blutgruppe AB Trockensub c Solv
Market launch
12/11/2024
Narcotic (BTM)
No

Other packaging sizes